June 9 : Privately held Element Biosciences said on Tuesday it had raised funds, including $175 million from longtime investor Samsung Electronics, to expand commercialisation of its genetic testing and research products. The San Diego-based company did not disclose the total size of the upsized Series E funding round, or its valuation. It also did not name the other investors. Samsung said in a statement that the investment would make it the largest shareholder in Element and deepen strategic